SLXNW Silexion Therapeutics Corp - Warrant
$0.01
价格 · 八月 18, 2026
截至...的财报数据 八月 14, 2026
SLXNW 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.01
市值
$4.1K
P/E (TTM)
0.0
每股收益 (TTM)
$8.96
营收 (TTM)
—
股息收益率
—
ROE
1718.9%
负债/权益
—
52周区间
$0 – $0
SLXNW 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$8.96
2023-12-31
→
2025-12-31
自由现金流
$-11M
2024-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
SLXNW
同行中位数
P/E (TTM)
0.0
—
P/B (市净率)
0.0
—
Price / FCF (股价/自由现金流)
-0.0
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
SLXNW
同行中位数
ROA
-236.4%
—
ROE
1718.9%
—
ROIC
-447.0%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
SLXNW
同行中位数
Current Ratio (流动比率)
2.4
—
Quick Ratio (速动比率)
2.2
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
SLXNW
同行中位数
EPS YoY
-97.7%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
SLXNW
同行中位数
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $7M | $6M | $4M | |
| SG&A Expense | $4M | $7M | $973.0K | |
| Operating Expenses | $12M | $13M | $5M | |
| Operating Income | $-12M | $-13M | $-5M | |
| Interest Income | $155.0K | $28.0K | $153.0K | |
| Other Non-op | $13.0K | $7.0K | $6.0K | |
| Pretax Income | $-12M | $-17M | $-5M | |
| Income Tax | $3.0K | $10.0K | $32.0K | |
| Net Income | $-12M | $-17M | $-5M | |
| EPS (Basic) | $8.96 | $394.94 | $44.23 | |
| EPS (Diluted) | $8.96 | $394.94 | $44.23 | |
| Shares (Basic) | 1,329,515 | 41,635 | 111,726 | |
| Shares (Diluted) | 1,329,515 | 41,635 | 111,726 | |
| EBITDA | $-12M | $-13M | · |
资产负债表 19
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $6M | $1M | $5M | |
| Prepaid Expense | $570.0K | $966.0K | $335.0K | |
| Other Current Assets | $49.0K | $62.0K | $24.0K | |
| Current Assets | $7M | $2M | $5M | |
| PP&E (Net) | $25.0K | $30.0K | $49.0K | |
| PP&E (Gross) | $108.0K | $99.0K | $133.0K | |
| Accum. Depreciation | $83.0K | $69.0K | $84.0K | |
| Total Assets | $7M | $3M | $5M | |
| Accounts Payable | $787.0K | $929.0K | $319.0K | |
| Accrued Liabilities | $859.0K | · | · | |
| Current Liabilities | $3M | $4M | $2M | |
| Capital Leases | $286.0K | $368.0K | $59.0K | |
| Total Liabilities | $5M | $7M | $2M | |
| Common Stock | $42.0K | $2.0K | · | |
| Paid-in Capital | $58M | $39M | $11M | |
| Retained Earnings | $-55M | $-43M | $-27M | |
| Stockholders' Equity | $3M | $-4M | $-15M | |
| Liabilities + Equity | $7M | $3M | $5M | |
| Shares Outstanding | 312,665 | 123,290,000 | 97,120,000 |
现金流 6
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $134.0K | $6M | $130.0K | |
| Operating Cash Flow | $-11M | $-8M | $-5M | |
| CapEx | $9.0K | $22.0K | $12.0K | |
| Investing Cash Flow | $-14.0K | $-22.0K | $573.0K | |
| Financing Cash Flow | $16M | $5M | $522.0K | |
| Free Cash Flow | $-11M | $-8M | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -236.4% | -555.3% | · | |
| ROE | 1718.9% | 169.7% | · | |
| ROIC | -447.0% | 315.3% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.4 | 0.6 | · | |
| Quick Ratio | 2.2 | 0.3 | · |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| EPS YoY | -97.7% | 792.9% | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-12M | $-17M | · | |
| Market Cap | $103M | · | · | |
| P/E | 0.0 | · | · | |
| P/B | 39.6 | · | · | |
| P / Tangible Book | 39.6 | · | · | |
| P / Cash Flow | -9.5 | · | · | |
| P / FCF | -9.5 | · | · | |
| Earnings Yield | 27151.5% | · | · |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $2M | $1M | $590.0K | $871.0K | $3M | $766.0K | $961.0K | $1M | $535.0K | $1M | |
| SG&A Expense | $1M | $1M | $1M | $1M | $1M | $1M | $5M | $619.0K | $289.0K | $471.0K | $196.0K | $179.0K | |
| Operating Expenses | $4M | $4M | $3M | $2M | $2M | $2M | $8M | $1M | $1M | $2M | $731.0K | $1M | |
| Operating Income | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-8M | $-1M | $-1M | $-2M | $-731.0K | $-1M | |
| Interest Income | $14.0K | $70.0K | $39.0K | $44.0K | $2.0K | $3.0K | $0 | $6.0K | $19.0K | · | · | · | |
| Other Non-op | $-115.0K | $6.0K | $4.0K | $260.0K | $3.0K | $2.0K | $3.0K | $2.0K | $0 | $1.0K | $1.0K | $3.0K | |
| Pretax Income | $-4M | $-4M | $-3M | $-2M | $-2M | $-2M | $-12M | $-1M | $-1M | $-2M | $-803.0K | $-2M | |
| Income Tax | · | $0 | $0 | $3.0K | · | $1.0K | $2.0K | $2.0K | $5.0K | $6.0K | $6.0K | $10.0K | |
| Net Income | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-12M | $-1M | $-1M | $-2M | $-809.0K | $-2M | |
| EPS (Basic) | $5.17 | $1.50 | $2.88 | $43.19 | $0.26 | $-89.40 | $274.25 | $197.80 | $12.29 | $41.03 | $0.78 | $6.54 | |
| EPS (Diluted) | $5.17 | $1.50 | $2.88 | $43.19 | $0.26 | $-89.40 | $274.25 | $197.80 | $12.29 | $41.03 | $0.78 | $6.54 | |
| Shares (Basic) | 687,353 | -7,161,871 | 1,132,658 | 57,952 | 6,779,205 | -120,746 | 43,213 | 7,442 | 111,726 | -893,805 | 1,005,531 | 252,462 | |
| Shares (Diluted) | 687,353 | -7,161,871 | 1,132,658 | 57,952 | 6,779,205 | -120,746 | 43,213 | 7,442 | 111,726 | -893,805 | 1,005,531 | 252,462 | |
| EBITDA | $-4M | · | $-3M | $-2M | $-2M | · | $-8M | $-1M | · | · | · | · |
资产负债表 19
| 指标 | 趋势 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $6M | $9M | $3M | $6M | $1M | $2M | $2M | · | $5M | · | · | |
| Prepaid Expense | $1M | $570.0K | $2M | $2M | $1M | $966.0K | $944.0K | $527.0K | · | $335.0K | · | · | |
| Other Current Assets | $111.0K | $49.0K | $47.0K | $63.0K | $58.0K | $62.0K | $80.0K | $66.0K | · | $24.0K | · | · | |
| Current Assets | $4M | $7M | $11M | $5M | $8M | $2M | $3M | $2M | · | $5M | · | · | |
| PP&E (Net) | $20.0K | $25.0K | $26.0K | $30.0K | $32.0K | $30.0K | $35.0K | $40.0K | · | $49.0K | · | · | |
| PP&E (Gross) | · | $108.0K | · | · | · | $99.0K | · | · | · | $133.0K | · | · | |
| Accum. Depreciation | · | $83.0K | · | · | · | $69.0K | · | · | · | $84.0K | · | · | |
| Total Assets | $4M | $7M | $12M | $6M | $8M | $3M | $3M | $3M | · | $5M | · | · | |
| Accounts Payable | · | $787.0K | $946.0K | $692.0K | $722.0K | $929.0K | $799.0K | $281.0K | · | $319.0K | · | · | |
| Accrued Liabilities | $933.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $4M | $3M | $3M | $2M | $2M | $4M | $4M | $2M | · | $2M | · | · | |
| Capital Leases | $226.0K | $286.0K | $311.0K | $337.0K | $334.0K | $368.0K | $0 | $8.0K | · | $59.0K | · | · | |
| Total Liabilities | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $2M | · | $2M | · | · | |
| Common Stock | $160.0K | $42.0K | $42.0K | $8.0K | $8.0K | $2.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $61M | $58M | $58M | $48M | $48M | $39M | $37M | $11M | · | $11M | · | · | |
| Retained Earnings | $-61M | $-55M | $-51M | $-47M | $-45M | $-43M | $-42M | $-30M | · | $-27M | · | · | |
| Stockholders' Equity | $44.0K | $3M | $7M | $120.0K | $3M | $-4M | $-5M | $-18M | · | $-15M | · | · | |
| Liabilities + Equity | $4M | $7M | $12M | $6M | $8M | $3M | $3M | $3M | · | $5M | · | · | |
| Shares Outstanding | 1,179,844 | 3,126,651,000 | 3,126,642 | 579,536 | 8,691,971 | 123,290,000 | 11,180,031 | 219,354 | · | 97,120,000 | · | · |
现金流 8
| 指标 | 趋势 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $197.0K | $38.0K | $38.0K | $37.0K | $21.0K | $0 | $6M | $32.0K | $32.0K | $34.0K | $32.0K | $32.0K | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-3M | $-1M | $-2M | $-1M | $-685.0K | $-2M | |
| CapEx | $0 | $2.0K | $0 | $1.0K | $6.0K | $0 | $16.0K | $0 | $6.0K | $4.0K | $6.0K | $2.0K | |
| Investing Cash Flow | $-1.0K | $-7.0K | $0 | $-1.0K | $-6.0K | $0 | $-16.0K | $0 | $-6.0K | $-4.0K | $72.0K | $-2.0K | |
| Stock Issued | $2M | · | $0 | $0 | · | · | $620.0K | · | · | · | · | · | |
| Net Stock Activity | $2M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $-221.0K | $9M | $-195.0K | $7M | $2M | $3M | $0 | · | $0 | $0 | $522.0K | |
| Free Cash Flow | $-3M | · | $-3M | $-3M | $-2M | · | $-3M | · | · | · | · | · |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -70.7% | · | -44.4% | -60.2% | -41.8% | · | -768.4% | -117.9% | · | · | · | · | |
| ROE | -4330.5% | · | -272.1% | 27.6% | -134.2% | · | 518.0% | 16.3% | · | · | · | · | |
| ROIC | · | · | -47.2% | -1905.6% | · | · | 175.5% | 7.6% | · | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | · | 4.0 | 2.4 | 3.2 | · | 0.9 | 1.0 | · | · | · | · | |
| Quick Ratio | 0.6 | · | 3.3 | 1.6 | 2.6 | · | 0.6 | 0.7 | · | · | · | · |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-12M | · | $-19M | $-18M | $-17M | · | $-16M | $-6M | · | · | · | · | |
| Market Cap | $39.4K | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | -0.0 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 155958.1% | · | · | · | · | · | · | · | · | · | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净收入 | $-12M | — | $-17M | — | — |
| 稀释后每股收益 (EPS) | $8.96 | — | $394.94 | — | — |
资产负债表
| 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 | 2.4 | — | 0.6 | — | — |
| 速动比率 | 2.2 | — | 0.3 | — | — |
现金流
| 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 自由现金流 | $-11M | — | $-8M | — | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 23 家申报者 · $141K 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 1 (+1 与上一季度对比) | 1 (-2 与上一季度对比) | 1 (0 与上一季度对比) | 1 (0 与上一季度对比) | +81K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Moringa Sponsor, LP, Moringa Partners Ltd, Ilan Levin | 2026年6月23日 | 10.60% | 修订 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.